QIAGEN N.V. (QGEN) recently signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.The latest acquisition aims to bolster QIAGEN’s next-generation sequencing (NGS) portfolio. Likely Trend of QGEN Stock Following the NewsFollowing the announcement, shares of the company moved north 2.3% to $42.96 yesterday.Over the past few quarters, the company has continuously integrated AI technology into ...